Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... Read More
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... Read More
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... Read More
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared wi... Read More
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherap... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746947) titled 'PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Regis... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746388) titled 'Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial' on July 29. Bri... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748598) titled 'HER2+ CNS Surveillance' on July 27. Brief Summary: A multi-centre, randomised study, to det... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746544) titled 'Study of Secutrelvir in Participants With COVID-19' on July 17. Brief Summary: The main pur... Read More